Trials / Completed
CompletedNCT00829907
A PET Study With ORM-12741
Effect of ORM-12741 on Receptor Occupancy Studied by Positron Emission Tomography; an Open, Single Dose, Dose Ranging Study in Healthy Males
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the effect of ORM-12741 on receptor occupancy by positron emission tomography with different doses and plasma concentrations. The pharmacokinetic profile and safety will also be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ORM-12741 | Single dose as a capsule, oral administration |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2009-01-27
- Last updated
- 2009-11-25
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00829907. Inclusion in this directory is not an endorsement.